COVID Archive — Page 15 of 35

Graphic with large white text reading “60 MINUTES” above a partial stopwatch on a red background.
April 12, 2021

VUMC team’s COVID-19 research featured on “60 Minutes”

James Crowe, MD, and members of his lab at Vanderbilt University Medical Center who have pioneered rapid development of monoclonal antibody treatments for life-threatening viral diseases including COVID-19, were featured Sunday on a CBS News 60 Minutes segment titled “The Last Pandemic.”

By Bill Snyder
James Crowe Jr., MD, and colleagues are exploring how the body’s immune system gears up to fight off infection.
April 12, 2021

Crowe receives SEC Faculty Achievement Award

James Crowe Jr., MD, a physician-scientist on the front lines of global research to eliminate human susceptibility to COVID-19 and other illnesses, is Vanderbilt University’s winner of the 2021 Southeastern Conference Faculty Achievement Award.

By Vanderbilt Health News
Close-up of a high-tech laboratory interface displaying the words “COVID-19” and “VIRUS,” with colorful circuit-like lines and data graphics.
April 8, 2021

VUMC creates new Adult Post-acute COVID Clinic

On March 15, a new clinic opened at Vanderbilt University Medical Center, the Adult Post-acute COVID Clinic. With no single location, the clinic is a coordinated service across adult general medicine and medical specialty clinics, with a telemedicine component to facilitate initial patient assessments in most cases.

By Paul Govern
Green-gloved laboratory worker holds two small tubes containing clear liquid over a blurred lab coat.
April 6, 2021

U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC

The U.S. government has reserved up to 700,000 doses of a monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca, officials have announced.

By Bill Snyder
Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
April 2, 2021

Investigational vaccine to be tested against COVID-19 variant

Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.

By Bill Snyder
Medical team members in white coats and blue scrubs joining their hands in a central stack, viewed from above.
April 1, 2021

COVID-19 met with intensive teamwork

Team members serving COVID-19 inpatients were more densely connected, interacting far more than their medical ICU counterparts.

By Paul Govern